CAS No.72496-41-4,Pirarubicin Suppliers

Products Categories

Pharmaceutical (101)
Organic Chemicals (20)
Others (10)
Reagent (2)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	72496-41-4
Name:	Pirarubicin
Article Data:	1

Formula:	C₃₂H₃₇NO₁₂
Molecular Weight:	627.645
Synonyms:	5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,[8S-[8a,10a(S*)]]-;5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,(8S,10S)- (9CI);(2''R)-4'-O-Tetrahydropyranyladriamycin;(2''R)-4'-O-Tetrahydropyranyldoxorubicin;4'-O-Tetrahydropyranyladriamycin;Pinorubicin;Pirarubicin;THP-Adriamycin;Therarubicin;
Density:	1.519 g/cm³
Melting Point:	188-192 °C (dec.)
Boiling Point:	834.659 °C at 760 mmHg
Flash Point:	458.586 °C
Solubility:	Soluble in water and methanol, slightly soluble in alcohol, chloroform, insoluble in are hexane and ethyl ether
Appearance:	Red crystalline powder
Hazard Symbols:	Xi
Risk Codes:	36/37/38
Safety:	26-37/39
PSA:	204.30000
LogP:	2.25250

Total:105 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 72496-41-4

Specification

The Pirarubicin, with the CAS registry number 72496-41-4, is also known as 4'-O-Tetrahydropyranyladriamycin. It belongs to the product categories of Chiral Reagents; Intermediates & Fine Chemicals; Pharmaceuticals. This chemical's molecular formula is C₃₂H₃₇NO₁₂ and molecular weight is 627.64. What's more, its systematic name is (8S,10S)-10-((3-Amino-2,3,6-trideoxy-4-O-(2R-tetrahydro-2H-pyran-2-yl)-α-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione. Its classification codes are: (1)Antineoplastic Agents; (2)Drug / Therapeutic Agent; (3)Mutation data. This chemical should be sealed and stored in a cool and dry place. Moreover, it should be protected from oxides. Its storage temperature is 2 - 8°C. It can be prepared by doxorubicin and dihydropyran, and it is an anthracycline-based anti-tumor antibiotic.

Physical properties of Pirarubicin are: (1)ACD/LogP: 3.852; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): 1.15; (4)ACD/LogD (pH 7.4): 2.30; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 14.08; (7)ACD/KOC (pH 5.5): 5.83; (8)ACD/KOC (pH 7.4): 83.87; (9)#H bond acceptors: 13; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 12; (12)Polar Surface Area: 204.3 Å²; (13)Index of Refraction: 1.67; (14)Molar Refractivity: 154.56 cm³; (15)Molar Volume: 413.309 cm³; (16)Polarizability: 61.272×10^-24cm³; (17)Surface Tension: 82.99 dyne/cm; (18)Density: 1.519 g/cm³; (19)Flash Point: 458.586 °C; (20)Enthalpy of Vaporization: 127.134 kJ/mol; (21)Boiling Point: 834.659 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. When using it, you need to wear suitable protective gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C2c1c(O)c6c(c(O)c1C(=O)c3cccc(OC)c23)C[C@@](O)(C(=O)CO)C[C@@H]6O[C@@H]5O[C@H]([C@@H](O[C@H]4OCCCC4)[C@@H](N)C5)C
(2)Std. InChI: InChI=1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19-,21+,22-,31+,32-/m0/s1
(3)Std. InChIKey: KMSKQZKKOZQFFG-YXRRJAAWSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intravenous	27800ug/kg (27.8mg/kg)		Journal of Antibiotics. Vol. 32, Pg. 1082, 1979.
mouse	LD50	unreported	14mg/kg (14mg/kg)		Biochemical Pharmacology. Vol. 38, Pg. 167, 1989.